{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:13:09Z","timestamp":1783710789602,"version":"3.55.0"},"reference-count":64,"publisher":"Xia & He Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["gene expr"],"published-print":{"date-parts":[[2017,11,27]]},"abstract":"<jats:p>\n                    Autosomal recessive polycystic kidney disease\/congenital hepatic fibrosis (ARPKD\/CHF) is a rare but fatal genetic disease characterized by progressive cyst development in the kidneys and liver. Liver cysts arise from aberrantly proliferative cholangiocytes accompanied by pericystic\n fibrosis and inflammation. Yes-associated protein (YAP), the downstream effector of the Hippo signaling pathway, is implicated in human hepatic malignancies such as hepatocellular carcinoma, cholangiocarcinoma, and hepatoblastoma, but its role in hepatic cystogenesis in ARPKD\/CHF is unknown.\n We studied the role of the YAP in hepatic cyst development using polycystic kidney (PCK) rats, an orthologous model of ARPKD, and in human ARPKD\/CHF patients. The liver cyst wall epithelial cells (CWECs) in PCK rats were highly proliferative and exhibited expression of YAP. There was increased\n expression of YAP target genes,\n                    <jats:italic>Ccnd1<\/jats:italic>\n                    (cyclin D1) and\n                    <jats:italic>Ctgf<\/jats:italic>\n                    (connective tissue growth factor), in PCK rat livers. Extensive expression of YAP and its target genes was also detected in human ARPKD\/CHF liver samples. Finally, pharmacological inhibition of YAP activity with verteporfin\n and short hairpin (sh) RNA-mediated knockdown of YAP expression in isolated liver CWECs significantly reduced their proliferation. These data indicate that increased YAP activity, possibly through dysregulation of the Hippo signaling pathway, is associated with hepatic cyst growth in ARPKD\/CHF.\n                  <\/jats:p>","DOI":"10.3727\/105221617x15034976037343","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T21:13:01Z","timestamp":1505509981000},"page":"313-326","source":"Crossref","is-referenced-by-count":11,"title":["Increased YAP Activation Is Associated With Hepatic Cyst Epithelial Cell Proliferation in ARPKD\/CHF"],"prefix":"10.14218","volume":"17","author":[{"given":"Lu","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genea","family":"Edwards","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Michael","family":"Manley","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren P.","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Septer","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Children\u2019s Mercy Hospital, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Manohar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele T.","family":"Pritchard","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udayan","family":"Apte","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","reference":[{"issue":"6","key":"b1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0092-8674(94)90137-6","article-title":"The polycystic kidney-disease-1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome-16","volume":"77","year":"1994","journal-title":"Cell"},{"issue":"4","key":"b2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/hmg\/4.4.575","article-title":"Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. The AMERICAN PKD1 Consortium (APKD1 Consortium)","volume":"4","year":"1995","journal-title":"Human Molecular Genetics"},{"issue":"5266","key":"b3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein","volume":"272","year":"1996","journal-title":"Science"},{"issue":"9","key":"b4","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1097\/01.ASN.0000028643.17901.42","article-title":"Genetics and pathogenesis of polycystic kidney disease","volume":"13","year":"2002","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"b5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00247-008-1064-x","article-title":"Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis (ARPKD\/CHF)","volume":"39","year":"2009","journal-title":"Pediatric Radiology"},{"key":"b6","article-title":"The cholangiopathies","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"b7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1586\/17474124.2.4.563","article-title":"Advances in management of polycystic liver disease","volume":"2","year":"2008","journal-title":"Expert Rev Gastroenterol Hepatol."},{"issue":"4","key":"b8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.1840400404","article-title":"Polycystic disease of the liver","volume":"40","year":"2004","journal-title":"Hepatology"},{"issue":"6","key":"b9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1752-8062.2011.00306.x","article-title":"Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease","volume":"4","year":"2011","journal-title":"Clin Transl Sci."},{"issue":"3","key":"b10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MOG.0b013e328328f4ff","article-title":"Cholangiociliopathies: genetics, molecular mechanisms and potential therapies","volume":"25","year":"2009","journal-title":"Curr Opin Gastroenterol."},{"issue":"5","key":"b11","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/hep.21199","article-title":"Polycystic liver disease: New insights into disease pathogenesis","volume":"43","year":"2006","journal-title":"Hepatology"},{"issue":"23","key":"b12","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","article-title":"YAP1 increases organ size and expands undifferentiated progenitor cells","volume":"17","year":"2007","journal-title":"Curr Biol."},{"issue":"1","key":"b13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1478-3231.2011.02646.x","article-title":"Deregulation of Hippo kinase signalling in human hepatic malignancies","volume":"32","year":"2012","journal-title":"Liver Int."},{"issue":"4","key":"b14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","article-title":"The hippo signaling pathway in development and cancer","volume":"19","year":"2010","journal-title":"Dev Cell"},{"issue":"5","key":"b15","doi-asserted-by":"crossref","first-page":"G493","DOI":"10.1152\/ajpgi.00056.2011","article-title":"Yes-associated protein is involved in proliferation and differentiation during postnatal liver development","volume":"302","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"4","key":"b16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo pathway in organ size control, tissue homeostasis, and cancer","volume":"163","year":"2015","journal-title":"Cell"},{"issue":"9","key":"b17","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/cdd.2015.10","article-title":"The Hippo pathway promotes cell survival in response to chemical stress","volume":"22","year":"2015","journal-title":"Cell Death Differ."},{"issue":"1","key":"b18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/path.2856","article-title":"Altered Hippo signalling in polycystic kidney disease","volume":"224","year":"2011","journal-title":"J Pathol."},{"issue":"12","key":"b19","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1681\/ASN.2010111173","article-title":"Epitope-tagged Pkhd1 tracks the processing, secretion, and localization of fibrocystin","volume":"22","year":"2011","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"b20","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/hep.26251","article-title":"Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents","volume":"57","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"b21","article-title":"Moderate (2%, v\/v) ethanol feeding alters hepatic wound healing after acute carbon tetrachloride exposure in mice","volume":"6","year":"2016","journal-title":"Biomolecules"},{"issue":"9","key":"b22","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/labinvest.3700448","article-title":"Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of autosomal recessive polycystic kidney disease","volume":"86","year":"2006","journal-title":"Lab Invest."},{"issue":"1","key":"b23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells","volume":"17","year":"2006","journal-title":"J Am Soc Nephrol."},{"key":"b24","first-page":"7","article-title":"Hematopoietic microenvironment in the fetal liver: Roles of different cell populations","volume":"2012","year":"2012","journal-title":"ISRN Cell Biol."},{"issue":"9","key":"b25","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1074\/jbc.M709037200","article-title":"Tumor suppressor LATS1 is a negative regulator of oncogene YAP","volume":"283","year":"2008","journal-title":"J Biol Chem."},{"issue":"8","key":"b26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1478-3231.2008.01826.x","article-title":"Connective tissue growth factor: A fibrogenic master switch in fibrotic liver diseases","volume":"28","year":"2008","journal-title":"Liver Int."},{"issue":"3","key":"b27","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/hep.22079","article-title":"Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activation","volume":"47","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"b28","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hep.27425","article-title":"Connective tissue growth factor and integrin alphavbeta6: A new pair of regulators critical for ductular reaction and biliary fibrosis in mice","volume":"61","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"b29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6346(03)00115-3","article-title":"Connective tissue growth factor (CTGF\/CCN2) in hepatic fibrosis","volume":"26","year":"2003","journal-title":"Hepatol Res."},{"issue":"14","key":"b30","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1101\/gad.1664408","article-title":"TEAD mediates YAP-dependent gene induction and growth control","volume":"22","year":"2008","journal-title":"Genes Dev."},{"issue":"10","key":"b31","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1101\/gad.888601","article-title":"TEAD\/TEF transcription factors utilize the activation domain of YAP65, a Src\/Yes-associated protein localized in the cytoplasm","volume":"15","year":"2001","journal-title":"Genes Dev."},{"issue":"12","key":"b32","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1101\/gad.192856.112","article-title":"Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP","volume":"26","year":"2012","journal-title":"Genes Dev."},{"issue":"5345","key":"b33","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1126\/science.278.5345.1907","article-title":"Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS","volume":"278","year":"1997","journal-title":"Science"},{"issue":"4","key":"b34","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2000.00991.x","article-title":"cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway","volume":"57","year":"2000","journal-title":"Kidney Int."},{"issue":"4","key":"b35","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2004.06.009","article-title":"cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA\/Src\/MEK\/ERK1\/2 pathway","volume":"41","year":"2004","journal-title":"J Hepatol."},{"issue":"5","key":"b36","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.humpath.2014.01.002","article-title":"The utility of Yes-associated protein (YAP) expression in the diagnosis of persistent neonatal cholestatic liver disease","volume":"45","year":"2014","journal-title":"Hum Pathol."},{"issue":"2","key":"b37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00247-008-1064-x","article-title":"Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis (ARPKD\/CHF)","volume":"39","year":"2009","journal-title":"Pediatr Radiol."},{"issue":"2","key":"b38","first-page":"89","article-title":"Autosomal recessive polycystic kidney disease: The prototype of the hepato-renal fibrocystic diseases","volume":"3","year":"2014","journal-title":"J Pediatr Genet."},{"key":"b39","article-title":"Evidence for a (pathogenic triumvirate) in congenital hepatic fibrosis in autosomal recessive polycystic kidney disease","year":"2016","journal-title":"Biomed Res Int."},{"issue":"4","key":"b40","doi-asserted-by":"crossref","first-page":"L344","DOI":"10.1152\/ajplung.00300.2014","article-title":"Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis","volume":"308","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"issue":"21","key":"b41","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.1602907","article-title":"Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control","volume":"21","year":"2007","journal-title":"Genes Dev."},{"issue":"33","key":"b42","doi-asserted-by":"crossref","first-page":"12405","DOI":"10.1073\/pnas.0605579103","article-title":"Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon","volume":"103","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"b43","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.cell.2006.05.030","article-title":"Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach","volume":"125","year":"2006","journal-title":"Cell"},{"issue":"11","key":"b44","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.humpath.2008.04.012","article-title":"Expression of Yes-associated protein in common solid tumors","volume":"39","year":"2008","journal-title":"Hum Pathol."},{"issue":"41","key":"b45","doi-asserted-by":"crossref","first-page":"11525","DOI":"10.1073\/pnas.1613121113","article-title":"Flow-dependent YAP\/TAZ activities regulate endothelial phenotypes and atherosclerosis","volume":"113","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"b46","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ajpath.2013.11.027","article-title":"HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis","volume":"184","year":"2014","journal-title":"Am J Pathol."},{"issue":"3","key":"b47","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/j.gastro.2011.11.036","article-title":"Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease","volume":"142","year":"2012","journal-title":"Gastroenterology"},{"issue":"14","key":"b48","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1073\/pnas.1309438111","article-title":"Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis","volume":"111","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"b49","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/hep.21143","article-title":"Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases","volume":"43","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"b50","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/hep.23511","article-title":"Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice","volume":"51","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"b51","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2010.04.010","article-title":"Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD","volume":"139","year":"2010","journal-title":"Gastroenterology"},{"issue":"6","key":"b52","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/hep.25872","article-title":"Cyclic AMP\/PKA-dependent paradoxical activation of Raf\/MEK\/ERK signaling in polycystin-2 defective mice treated with sorafenib","volume":"56","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"b53","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1073\/pnas.0911427107","article-title":"Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver","volume":"107","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"b54","doi-asserted-by":"crossref","first-page":"8248","DOI":"10.1073\/pnas.0912203107","article-title":"The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis","volume":"107","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"b55","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1073\/pnas.0911409107","article-title":"Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression","volume":"107","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"b56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","article-title":"Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene","volume":"16","year":"2009","journal-title":"Cancer Cell"},{"issue":"3","key":"b57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein","volume":"30","year":"2002","journal-title":"Nat Genet."},{"issue":"1","key":"b58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1538\/expanim.49.51","article-title":"Characterization of a novel polycystic kidney rat model with accompanying polycystic liver","volume":"49","year":"2000","journal-title":"Exp Anim."},{"issue":"5","key":"b59","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0002-9440(10)63427-X","article-title":"Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease","volume":"165","year":"2004","journal-title":"Am J Pathol."},{"issue":"4","key":"b60","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/hep.24108","article-title":"Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells","volume":"53","year":"2011","journal-title":"Hepatology"},{"issue":"16","key":"b61","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.febslet.2014.04.012","article-title":"YAP\/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth","volume":"588","year":"2014","journal-title":"FEBS Lett."},{"issue":"2","key":"b62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11154-015-9313-4","article-title":"Physiological mechanisms and therapeutic potential of bone mechanosensing","volume":"16","year":"2015","journal-title":"Rev Endocr Metab Disord."},{"issue":"3","key":"b63","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep.28382","article-title":"Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis","volume":"63","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"b64","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9394(01)00967-9","article-title":"Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization\u2014verteporfin in photodynamic therapy report 2","volume":"131","year":"2001","journal-title":"Am J Ophthalmol."}],"container-title":["Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/cog\/ge\/2017\/00000017\/00000004\/art00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:16:54Z","timestamp":1783707414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.3727\/105221617X15034976037343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,27]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,11,27]]}},"alternative-id":["1052-2166(20171127)17:4L.313;1-"],"URL":"https:\/\/doi.org\/10.3727\/105221617x15034976037343","relation":{},"ISSN":["1052-2166"],"issn-type":[{"value":"1052-2166","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11,27]]}}}